◆英語タイトル:Reckitt Benckiser Group Plc (RB.) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9918
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Reckitt Benckiser Group Plc (RB) is a consumer health and hygiene company that manufactures and markets household, toiletry and health care products. These consist of air fresheners, laundry products, dishwashing detergents, disinfectant sprays, water softeners, household cleaners, and personal care products. It also sells over-the-counter (OTC) drugs, cough and congestion tablets. Sinus relief products, gastric liquids, hair removal and pest control products. The company markets these products under various Powerbrands including Nurofen, Strepsils, Mucinex, Dettol, Lysol, Veet, Harpic, Mortein, Finish and Vanish, for a few. It has operations across Asia Pacific, Europe, North America and the Middle East and Africa regions. RB is headquartered in Slough, Berkshire, the UK.
Reckitt Benckiser Group Plc (RB.) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Reckitt Benckiser Group Plc, Medical Devices Deals, 2012 to YTD 2018 10
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Reckitt Benckiser Exercises Option to Acquire OTC Products of Bristol-Myers Squibb for USD317 Million 12
Reckitt Benckiser To Acquire K-Y Lubricants Brand From McNEIL-PPC 14
Partnerships 15
Mead Johnson Nutrition Forms Joint Venture With Sancor Cooperativas Unidas 15
Licensing Agreements 17
Reckitt Benckiser Amends Licensing Agreement With Bristol-Myers Squibb For OTC Brands 17
Asset Transactions 19
G.R. Lane Health Products Acquires Derbac M and Earex Brands From Reckitt Benckiser 19
Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For US$4 Million 20
Acquisition 21
Reckitt Benckiser Plans To Sell Reckitt Benckiser Pharma For US$3.2 Billion 21
Reckitt Benckiser Completes Acquisition Of Schiff Nutrition International For US$1.4 Billion 22
SSL International Acquires Remaining 25% Stake In Beleggingsmaatschappij Lemore 24
Reckitt Benckiser Group Plc – Key Competitors 25
Reckitt Benckiser Group Plc – Key Employees 26
Reckitt Benckiser Group Plc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 30
Financial Announcements 30
Feb 19, 2018: Reckitt Benckiser reports full year 2017 results 30
Jul 24, 2017: Reckitt Benckiser reports half year 2017 results 33
Legal and Regulatory 34
Mar 08, 2017: Absorption Pharmaceuticals: Maker of Premature Ejaculation Medication Promescent Files Suit Against British Conglomerate for Trade Secret Theft and Fraud 34
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Reckitt Benckiser Group Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Reckitt Benckiser Group Plc, Medical Devices Deals, 2012 to YTD 2018 10
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Reckitt Benckiser Exercises Option to Acquire OTC Products of Bristol-Myers Squibb for USD317 Million 12
Reckitt Benckiser To Acquire K-Y Lubricants Brand From McNEIL-PPC 14
Mead Johnson Nutrition Forms Joint Venture With Sancor Cooperativas Unidas 15
Reckitt Benckiser Amends Licensing Agreement With Bristol-Myers Squibb For OTC Brands 17
G.R. Lane Health Products Acquires Derbac M and Earex Brands From Reckitt Benckiser 19
Alliance Pharma Completes Acquisition Of UK And Irish Rights To Anbesol And Ashton & Parsons From Reckitt Benckiser For US$4 Million 20
Reckitt Benckiser Plans To Sell Reckitt Benckiser Pharma For US$3.2 Billion 21
Reckitt Benckiser Completes Acquisition Of Schiff Nutrition International For US$1.4 Billion 22
SSL International Acquires Remaining 25% Stake In Beleggingsmaatschappij Lemore 24
Reckitt Benckiser Group Plc, Key Competitors 25
Reckitt Benckiser Group Plc, Key Employees 26
Reckitt Benckiser Group Plc, Subsidiaries 27
List of Figures
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Reckitt Benckiser Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Reckitt Benckiser Group Plc, Medical Devices Deals, 2012 to YTD 2018 10